Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

PORCN inhibitor

DRUG CLASS:

PORCN inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

RSPO3 fusion	Gastric Cancer	RSPO3 fusion	Gastric Cancer	pembrolizumab + CGX1321 Sensitive: C3 – Early Trials pembrolizumab + CGX1321 Sensitive : C3	pembrolizumab + CGX1321 Sensitive: C3 – Early Trials pembrolizumab + CGX1321 Sensitive : C3
NOTCH1 mutation	Squamous Cell Carcinoma of Head and Neck	NOTCH1 mutation	Squamous Cell Carcinoma of Head and Neck	WNT974 Sensitive: D – Preclinical WNT974 Sensitive : D	WNT974 Sensitive: D – Preclinical WNT974 Sensitive : D
NOTCH1 C478F	Squamous Cell Carcinoma of Head and Neck	NOTCH1 C478F	Squamous Cell Carcinoma of Head and Neck	WNT974 Sensitive: D – Preclinical WNT974 Sensitive : D	WNT974 Sensitive: D – Preclinical WNT974 Sensitive : D
RNF43 mutation	Colorectal Cancer	RNF43 mutation	Colorectal Cancer	PORCN inhibitor Sensitive: D – Preclinical PORCN inhibitor Sensitive : D	PORCN inhibitor Sensitive: D – Preclinical PORCN inhibitor Sensitive : D